Suchergebnisse - "Ritonavir"

PubPharm (270)

91

Beneficial effects of a switch to a Lopinavir/ritonavir-containing regimen for patients with partial or no immune reconstitution with highly active antiretroviral therapy despite complete viral suppression

enthalten in: AIDS research and human retroviruses | 2011

von Pitrak, D. | Estes, R. | Novak, R. | +2

92

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients : The ACHIEV2E Collaboration Study Group

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2011

von Benard, A. | van Sighem, A. | Taieb, A. | +110

93

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

enthalten in: AIDS (London, England) | 2011

von Cahn, P. | Fourie, J. | Grinsztejn, B. | +8

94

Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir

enthalten in: Pharmacotherapy | 2011

von Dlamini, J. | Hu, Z. | Somaroo, H. | +4

95

Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy

enthalten in: Antiviral therapy | 2011

von Pulido, F. | Arribas, J. | Hill, A. | +2

96

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

97

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2010

von Yilmaz, A. | Verhofstede, C. | D'Avolio, A. | +5

98

Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice

enthalten in: Journal of medical virology | 2010

von Prosperi, M. | Zazzi, M. | Punzi, G. | +113

99

A 48-week pilot study switching suppressed patients to darunavir/ritonavir and etravirine from enfuvirtide, protease inhibitor(s), and non-nucleoside reverse transcriptase inhibitor(s)

enthalten in: AIDS research and human retroviruses | 2010

von Ruane, P. | Alas, B. | Ryan, R. | +2

100

A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa

enthalten in: The Journal of infectious diseases | 2010

von Phidisa II Writing Team for Project Phidisa | Ratsela, A. | Polis, M. | +56

CommentIn: J Infect Dis. 2010 Nov 15;202(10):1467-9. - PMID 20942649